Continuous improvement of bone mineral density two years post zoledronic acid discontinuation in patients with thalassemia-induced osteoporosis: long-term follow-up of a randomized, placebo-controlled trial
- PMID: 18698086
- DOI: 10.3324/haematol.12849
Continuous improvement of bone mineral density two years post zoledronic acid discontinuation in patients with thalassemia-induced osteoporosis: long-term follow-up of a randomized, placebo-controlled trial
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
